Earth Science Tech (ETST) Cost of Revenue (2011 - 2026)
Earth Science Tech's (ETST) quarterly Cost of Revenue came in at $280686.0 in Q1 2026, up 105.0% YoY from $136917.8 in Q1 2025, and up 12.13% on a QoQ basis from $250332.0 in Q4 2025.
Earth Science Tech (ETST) Cost of Revenue (2011 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 15 years of Cost of Revenue data on file, last reported at $280686.0 in Q1 2026.
- Quarterly Cost of Revenue rose 105.0% year-over-year to $280686.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 218.94% YoY) and the FY2026 annual result came in at $1.0 million, down 5.68% from the prior year.
- Cost of Revenue grew to $280686.0 in Q1 2026, from $250332.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $2.3 million in Q3 2025 to a low of -$5.6 million in Q1 2025.
- A 5-year average of $265436.4 and a median of $211446.0 in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2024 — Cost of Revenue jumped 43652.25% — and 2025, when it plunged 396.15%.
- Tracing ETST's Cost of Revenue over 5 years: stood at $4200.0 in 2022, then jumped by 33552.71% to $1.4 million in 2023, then plunged by 85.1% to $210549.0 in 2024, then increased by 18.89% to $250332.0 in 2025, then increased by 12.13% to $280686.0 in 2026.
- The last three Cost of Revenue figures came in at $280686.0 (Q1 2026), $250332.0 (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Earth Science Tech | 31.63 Mn | 28.84 Mn | 6.28 Mn | 2.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.75 Mn |
| Jun 30, 2026 | 2.75 Mn |
| Mar 31, 2026 | 280,686.00 |
| Mar 31, 2026 | 280,686.00 |
| Dec 31, 2025 | 250,332.00 |
| Dec 31, 2025 | 250,332.00 |
| Sep 30, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 633,926.00 |
| Jun 30, 2025 | 633,926.00 |
| Mar 31, 2025 | -5.61 Mn |
| Mar 31, 2025 | -5.61 Mn |
| Dec 31, 2024 | 210,549.00 |
| Dec 31, 2024 | 210,549.00 |
| Sep 30, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 211,446.00 |
| Jun 30, 2024 | 211,446.00 |
| Mar 31, 2024 | 1.89 Mn |
| Mar 31, 2024 | 1.89 Mn |